PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18519569-6	2008	Activation of an anti-inflammatory pathway by pre-exposure to the adenosine A(2A) receptor agonist CGS21680 prevented the inducing effect of LPS/IFNgamma on HIF-1 and TfR1 expression by inhibiting NF-kappaB activity, whereas treatment with CGS21680 alone increased HIF-1-mediated TfR1 expression by means of an NF-kappaB-independent signaling pathway.	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	99-107	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	197-206	
18519569-6	2008	Activation of an anti-inflammatory pathway by pre-exposure to the adenosine A(2A) receptor agonist CGS21680 prevented the inducing effect of LPS/IFNgamma on HIF-1 and TfR1 expression by inhibiting NF-kappaB activity, whereas treatment with CGS21680 alone increased HIF-1-mediated TfR1 expression by means of an NF-kappaB-independent signaling pathway.	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	99-107	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	311-320	
21183557-12	2011	CGS21680 inhibited the activation of NFkappaB and suppressed the expression of IFN-gamma, MCP-1 and MHC-II in MRL/lpr splenocytes.	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	0-8	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	37-45